Mangoceuticals, Inc. (MGRX) Revenue History
Annual and quarterly revenue from 2021 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MGRX Revenue Growth
MGRX Revenue Analysis (2021–2024)
As of May 6, 2026, Mangoceuticals, Inc. (MGRX) generated trailing twelve-month (TTM) revenue of $466,908, reflecting significant decline in growth of -36.8% year-over-year. The most recent quarter (Q3 2025) recorded $84,246 in revenue, down 49.9% sequentially.
Looking at the longer-term picture, MGRX's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $731,493 in 2023.
When compared to Healthcare sector peers including HIMS (+59.0% YoY), AMWL (-30.3% YoY), and TDOC (-1.5% YoY), MGRX has underperformed the peer group in terms of revenue growth. Compare MGRX vs HIMS →
MGRX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MGRXCurrent | $466,908 | -36.8% | - | -1294.4% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% | |
 AMWL | $249M | -30.3% | +0.3% | -42.2% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% | |
 OPRX | $109M | +18.8% | +20.4% | 10.7% |
MGRX Historical Revenue Data (2021–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $616K | -15.8% | $380K | 61.7% | $-7,972,000 | -1294.4% |
| 2023 | $731K | +8083.2% | $432K | 59.0% | $-9,218,890 | -1260.3% |
| 2022 | $9K | - | $5K | 54.3% | $-1,991,582 | -22279.7% |
| 2021 | $0 | - | $0 | - | $-17,520 | - |
See MGRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MGRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MGRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMGRX — Frequently Asked Questions
Quick answers to the most common questions about buying MGRX stock.
Is MGRX's revenue growth accelerating or slowing?
MGRX revenue declined -36.8% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $466908.00. This reverses the prior growth trend.
What is MGRX's long-term revenue growth rate?
Mangoceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -36.8% is below this long-term average.
How is MGRX's revenue distributed by segment?
MGRX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2024 are available for download. Segment mix reveals concentration and diversification trends.